გამოგვყევი
GE
GE

Life4me+-ის ერთ-ერთი მთავარი მიზანია აივ, სხვა სგგი, ჰეპატიტი C და ტუბერკულოზის ახალი შემთხვევების პრევენცია.

აპლიკაცია ეხმარება აივ დადებით პირებს ექიმებთან ანონიმური კომუნიკაციის დამყარებაში. ეს ყველაფერი დაგეხმარებათ ორგანიზება გაუკეთოთ მედიკამენტების მიღების განრიგს და დააყენოთ ფარული და პერსონალიზებული შეხსენებები.

ყველა სიახლე / ოქტომბერი 2017

არქივი

✕
10 ოქტომბერი 2017
5539
The International AIDS Society mourns the passing of Amsterdam Mayor

The International AIDS Society mourns the passing of Amsterdam Mayor

“To stop the urban HIV epidemic, inclusivity is essential,” Mayor van der Laan said. His leadership vividly reflected this commitment to an open, transparent and participatory fight against HIV.
10 ოქტომბერი 2017
5399
Durable end to the HIV/AIDS pandemic likely will require an HIV vaccine

Durable end to the HIV/AIDS pandemic likely will require an HIV vaccine

Despite remarkable gains in the treatment and prevention of HIV infection, development of an effective HIV vaccine likely will be necessary to achieve a durable end to the HIV/AIDS pandemic, according to a new commentary from Anthony S. Fauci, M.D., director of NIAID.
10 ოქტომბერი 2017
5964
California lowers penalty for knowingly exposing partners to HIV

California lowers penalty for knowingly exposing partners to HIV

The law previously punished people who knowingly exposed or infected others with HIV by up to eight years in prison. This new legislation will lower jail time to a maximum of six months.
9 ოქტომბერი 2017
5366
Many MSM currently taking PrEP would switch to injectable forms of the therapy

Many MSM currently taking PrEP would switch to injectable forms of the therapy

Approximately a third of gay and bisexual men who are currently taking oral pre-exposure prophylaxis would prefer long-acting injectable PrEP should it become available.
9 ოქტომბერი 2017
5060
Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab

Theratechnologies Announces 48-Week Efficacy and Safety Results for Ibalizumab

Theratechnologies Inc. today announced 48-week efficacy and safety results for ibalizumab in patients infected with multidrug resistant HIV-1.
9 ოქტომბერი 2017
6493
Gay Men May Be Able to Self-Check for Anal Cancer

Gay Men May Be Able to Self-Check for Anal Cancer

A recent study found that self- and partner exams were a fairly reliable way of identifying anal abnormalities that may be signs of cancer.
9 ოქტომბერი 2017
5893
ART Limits Appropriate Contraceptive Options for Women with HIV

ART Limits Appropriate Contraceptive Options for Women with HIV

Hormonal contraceptives with potential drug-drug interactions with antiretroviral therapy are commonly prescribed to women living with HIV, according to retrospective study findings.
8 ოქტომბერი 2017
6062
How UNAIDS “90-90-90” target looks in Russia today

How UNAIDS “90-90-90” target looks in Russia today

According to the Federal AIDS Center estimates, the UNAIDS "90-90-90" target in Russia looks like "64-33-75".
6 ოქტომბერი 2017
4873
Electronic systems in healthcare improve adherence to HIV treatment

Electronic systems in healthcare improve adherence to HIV treatment

Electronic systems in healthcare (e. g. mobile apps or websites) have a number of positive effects to people living with HIV
6 ოქტომბერი 2017
5209
Risk for Many Cancers Has Fallen for People With HIV

Risk for Many Cancers Has Fallen for People With HIV

Risk for Many Cancers Has Fallen for People With HIVSince the advent of effective combination antiretroviral treatment two decades ago, the risk of many cancers has fallen for people living with HIV. However, this population’s risk for a slew of cancers remains elevated ...
ჩვენ ვიყენებთ ქუქის, რათა გავაუმჯობესოთ თქვენ მიერ საიტის მოხმარება
ვებ-გვერდზე ნებისმიერ ღილაკზე დაჭერით თქვენ გვაძლევთ უფლებას, რომ გამოვიყენოთ თქვენი cookies.